Key Takeaways “Made in USA” is a FTC-regulated term: for products to carry the unqualified claim, “all or virtually all” of the manufacturing and significant components must originate in the U.S. — yet dog supplement labels rarely disclose the country of origin of active ingredients. Customs data, supplier filings, and label audits show that the…

Key Takeaways Affiliate disclosure compliance across canine health blogs remains inconsistent, with FTC endorsement guides requiring clear and conspicuous disclosure that many sites bury in footer text or omit entirely. Network analysis of “independent” review sites reveals common patterns: shared Amazon Associates IDs, identical product photography, and overlapping monetized link clusters that suggest undisclosed commercial…

Key Takeaways Subscription dog supplement brands deploy an average of 4.3 cancellation steps, with the highest-friction brand requiring 9 separate clicks or pages to cancel. Hidden auto-renewal disclosures sit inside pre-checked boxes, footer links, or Terms of Service paragraphs in 7 of the 12 audited brands. Retention dark patterns (“save 40%” offers, countdown timers, “are…

Key Takeaways Between 2021 and 2026, the FDA Enforcement Report database recorded 47 pet supplement and treat withdrawal events affecting canine products, with microbial contamination and labeling/potency deviations accounting for the majority of documented causes. Pathogen-driven events (Salmonella, Listeria, and Aspergillus) cluster disproportionately around single-product or small-batch operations rather than large-volume contract manufacturers. Labeling and…

Key Takeaways Soft chew supplements carry roughly 40–60% excipient load by weight, which directly squeezes the budget available for active ingredients. Heat extrusion (tunnel ovens typically running 130–160°F) and moisture control (water activity targets of 0.6 or below) impose hard limits on how much live bacterial culture a chew can deliver. Format economics explain why…

Key Takeaways “Veterinary formulated” is a marketing claim with no federal regulatory definition — the FDA, FTC, and AAFCO do not certify, define, or enforce this phrase. Substantiation for such claims falls under FTC jurisdiction: advertisers must have competent and reliable scientific evidence, but no pre-market approval is required. AAFCO regulates nutritional adequacy statements on…

Key Takeaways “Clinically proven” is a marketing phrase with no single legal definition, but the FTC’s substantiation doctrine requires claims to be backed by evidence that matches the claim’s scope. Substantiation tiers range from anecdotal testimonials (weakest) through in vitro data, animal-model studies, and randomized controlled trials (strongest). The National Advertising Division (NAD) handles most…

Key Takeaways Private-equity acquisitions of pet supplement brands have accelerated sharply since 2020, with deal values routinely exceeding half a billion dollars for category leaders. PE-owned brands often show the same post-acquisition pattern: formulation simplification, label redesigns, and reduced third-party testing — changes that can compromise product quality without triggering a single recall. Litigation and…

Key Takeaways The pet supplement industry relies heavily on a small number of contract manufacturers and co-packers, meaning many “brands” share production lines, formulations, or even finished products. White-label and private-label business models dominate chews and soft chews, and most consumer-facing brands disclose almost nothing about who actually makes their products. Manufacturing concentration creates real…